ATE142695T1 - Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen - Google Patents

Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen

Info

Publication number
ATE142695T1
ATE142695T1 AT90901507T AT90901507T ATE142695T1 AT E142695 T1 ATE142695 T1 AT E142695T1 AT 90901507 T AT90901507 T AT 90901507T AT 90901507 T AT90901507 T AT 90901507T AT E142695 T1 ATE142695 T1 AT E142695T1
Authority
AT
Austria
Prior art keywords
development
leukemia
inhibiting factor
livestock species
embryonal cells
Prior art date
Application number
AT90901507T
Other languages
English (en)
Inventor
Nicholas Martin Gough
Tracey Ann Willson
Robert Frederick Seamark
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Application granted granted Critical
Publication of ATE142695T1 publication Critical patent/ATE142695T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT90901507T 1989-01-10 1990-01-09 Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen ATE142695T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ222089 1989-01-10
AUPJ270689 1989-02-13
AUPJ486089 1989-06-23

Publications (1)

Publication Number Publication Date
ATE142695T1 true ATE142695T1 (de) 1996-09-15

Family

ID=27157475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90901507T ATE142695T1 (de) 1989-01-10 1990-01-09 Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen

Country Status (8)

Country Link
US (3) US5418159A (de)
EP (1) EP0453453B1 (de)
JP (1) JP2974760B2 (de)
AT (1) ATE142695T1 (de)
CA (1) CA2045126A1 (de)
DE (1) DE69028514T2 (de)
NZ (1) NZ232072A (de)
WO (1) WO1990008188A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0453453B1 (de) * 1989-01-10 1996-09-11 Amrad Corporation Limited Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
JP3375957B2 (ja) * 1990-07-09 2003-02-10 アムラド・コーポレイション・リミテッド 白血病抑制因子を用いる胚の増強移植、増殖及び維持
US5589582A (en) * 1992-10-27 1996-12-31 Biotransplant, Inc. Polynucleotides en coding porcine cytokines
US5849991A (en) 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
JPH09508277A (ja) * 1994-01-27 1997-08-26 ブレサゲン リミテッド ヒト異種移植における超急性拒絶の管理のための物質及び方法
US6271436B1 (en) 1996-10-11 2001-08-07 The Texas A & M University System Cells and methods for the generation of transgenic pigs
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
AUPP053197A0 (en) 1997-11-26 1997-12-18 Amrad Operations Pty. Limited Compositions
WO1999042122A1 (en) * 1998-02-19 1999-08-26 University Of Southern California Method of promoting embryonic stem cell proliferation
EP1094831A4 (de) * 1998-07-06 2004-11-03 Us Gov Health & Human Serv Zusammensetzungen und verfahren zur (in vitro) fertilisation
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
US6635802B1 (en) 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
JP3723839B2 (ja) * 2001-06-07 2005-12-07 国立大学法人広島大学 ニワトリの白血病阻止因子（ｌｉｆ）、及びそれをコードする遺伝子
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
DE60239420D1 (de) * 2001-12-21 2011-04-21 Thrombogenics Nv Zusammensetzungen für die in vitro herleitung und kultur embryonaler stammzellinien mit keimbahnübertragungsfähigkeit und für die kultur adulter stammzellen
AU2002218893A1 (en) * 2001-12-21 2003-07-09 Thromb-X Nv Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
GB0220145D0 (en) * 2002-08-30 2002-10-09 Thromb X Nv Novel compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
US20060269552A1 (en) * 2003-06-09 2006-11-30 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
US7409963B2 (en) * 2004-11-05 2008-08-12 Go Papa, Lllp Corner molding and stop assembly for collapsible shelter
EP1962719A4 (de) 2005-08-29 2011-05-04 Technion Res And Dev Of Foundation Ltd Medien zur züchtung von stammzellen
DK3441459T3 (da) * 2006-08-02 2021-06-07 Technion Res & Dev Foundation Fremgangsmåder til ekspansion af embryonale stamceller i en suspensionskultur
WO2011125948A1 (ja) 2010-04-02 2011-10-13 独立行政法人理化学研究所 Ｅｓ細胞の製造方法
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
MX385372B (es) 2015-03-23 2025-03-18 Evestra Inc Nuevos agentes citotóxicos que preferentemente se dirigen al factor inhibidor de leucemia (lif) para el tratamiento de malignidades y como nuevos agentes anticonceptivos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643746A1 (de) * 1986-12-20 1988-06-30 Stohrer Doduco Gmbh & Co Tauchverfahren und vorrichtung zum elektrolytischen beschichten von platten, insbesondere von elektrischen leiterplatten
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
JPH03503841A (ja) * 1988-01-29 1991-08-29 エイビーエス・グローバル・インコーポレーテツド ウシ胚のインビトロ培養
AU623922B2 (en) * 1988-08-04 1992-05-28 Amrad Operations Pty. Limited In vitro propagation of embryonic stem cells
EP0453453B1 (de) * 1989-01-10 1996-09-11 Amrad Corporation Limited Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
JP3375957B2 (ja) * 1990-07-09 2003-02-10 アムラド・コーポレイション・リミテッド 白血病抑制因子を用いる胚の増強移植、増殖及び維持

Also Published As

Publication number Publication date
NZ232072A (en) 1992-05-26
US5418159A (en) 1995-05-23
WO1990008188A1 (en) 1990-07-26
US5962321A (en) 1999-10-05
US5641676A (en) 1997-06-24
JP2974760B2 (ja) 1999-11-10
JPH04502554A (ja) 1992-05-14
EP0453453A1 (de) 1991-10-30
EP0453453B1 (de) 1996-09-11
EP0453453A4 (en) 1992-10-14
DE69028514D1 (de) 1996-10-17
CA2045126A1 (en) 1990-07-11
DE69028514T2 (de) 1997-02-20

Similar Documents

Publication Publication Date Title
ATE142695T1 (de) Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
Echalier et al. In vitrol culture of Drosophila melanogaster embryonic cells
DK0610474T3 (da) Dyrecellekultur
DK720488A (da) Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
ES2120946T3 (es) Sistemas y medios de cultivo celular.
DE69027526D1 (de) Herstellung von proteinen mittels homologer rekombination
ATE175994T1 (de) (in vitro)-vermehrung von embryonalen stammzellen unter verwendung von leukämie-inhibitionsfaktor (lif)
DE69637656D1 (de) Methoden zur Züchtung von Tierzellen
NO20003424D0 (no) Kommersielt anvendelig kjønns-spesifikk inseminasjon av pattedyr
DE60017875D1 (de) Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen
DE69231485D1 (de) Verwendung von porösem Calciumcarbonat als Trägermaterial für in vitro Zellkulturen.
Egloff et al. SIZE RELATIONS OF THE FILTERING AREA OF TWO DAPHNIA SPECIES 1
Chan et al. Culture of erythropoietic cells from chick blastoderms
Ravindranath The hemocytes of an isopod Ligia exotica Roux
Fedoroff Tracing glial cell lineages by colony formation in primary cultures
Ellinger et al. Amphibian cell culture: established fibroblastic line from embryos of the discoglossid frog, Bombina orientalis
JPS6451079A (en) Serumfree medium for cultivation of human/human hybridoma
Holeckova et al. Aging in cell and tissue culture
Kambysellis et al. In vitro development of insect cells: III. Effects of ecdysone on neonatal larval cells
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
DE3871530D1 (de) Vorrichtung zum kultivieren von ruhenden zellen in einem bioreaktor.
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
ES381368A1 (es) Un metodo de cultivar un genero de celulas hepaticas epite-liales humanas heteroploides.
Fighetti et al. Possible involvement of nuclei in cadmium-induced modifications of cultured cells

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee